Summit Therapeutics (NASDAQ: SMMT) is one of those stocks that have been quite explosive: The share price of the clinical-stage drugmaker has skyrocketed by nearly 390% over the last 12 months. Summit ...
TSA Checkpoint 2 at Charlotte Douglas International Airport will open Monday, March 24 for limited passenger screenings.
Stoke Therapeutics (NASDAQ:STOK – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC ...
(El Centro Police Department announces their next DUI Checkpoint.)...It has been scheduled for this Saturday.
Announces that the external Data Safety Monitoring Board (DSMB), an independent group of experts who review and monitor the ...
Announces that the external Data Safety Monitoring Board (DSMB), an independent group of experts who review and monitor the safety data of the BriaCell clinical study to determine if the study should ...
4d
Fintel on MSNRodman & Renshaw Initiates Coverage of BioXcel Therapeutics (BTAI) with Buy RecommendationFintel reports that on March 19, 2025, Rodman & Renshaw initiated coverage of BioXcel Therapeutics (NasdaqCM:BTAI) with a Buy ...
Q4 2024 Earnings Call Transcript March 18, 2025 MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...
AlphaQuest LLC lowered its position in Pliant Therapeutics, Inc. (NASDAQ:PLRX – Free Report) by 73.9% during the 4th quarter, ...
The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...
About PD-1 Inhibitors PD-1 inhibitors work by blocking the PD-1 (programmed death-1) receptor on T cells, preventing cancer cells from evading the immune system and restoring the body’s ability to ...
Indaptus advanced its Decoy20 trial to test a combination with tislelizumab, aiming to enhance checkpoint inhibitor effectiveness in cancer treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results